Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Neurosci ; 30(39): 13110-5, 2010 Sep 29.
Article in English | MEDLINE | ID: mdl-20881129

ABSTRACT

SorCS1 and SorL1/SorLA/LR11 belong to the sortilin family of vacuolar protein sorting-10 (Vps10) domain-containing proteins. Both are genetically associated with Alzheimer's disease (AD), and SORL1 expression is decreased in the brains of patients suffering from AD. SORCS1 is also genetically associated with types 1 and 2 diabetes mellitus (T1DM, T2DM). We have undertaken a study of the possible role(s) for SorCS1 in metabolism of the Alzheimer's amyloid-ß peptide (Aß) and the Aß precursor protein (APP), to test the hypothesis that Sorcs1 deficiency might be a common genetic risk factor underlying the predisposition to AD that is associated with T2DM. Overexpression of SorCS1cß-myc in cultured cells caused a reduction (p = 0.002) in Aß generation. Conversely, endogenous murine Aß(40) and Aß(42) levels were increased (Aß(40), p = 0.044; Aß(42), p = 0.007) in the brains of female Sorcs1 hypomorphic mice, possibly paralleling the sexual dimorphism that is characteristic of the genetic associations of SORCS1 with AD and DM. Since SorL1 directly interacts with Vps35 to modulate APP metabolism, we investigated the possibility that SorCS1cß-myc interacts with APP, SorL1, and/or Vps35. We readily recovered SorCS1:APP, SorCS1:SorL1, and SorCS1:Vps35 complexes from nontransgenic mouse brain. Notably, total Vps35 protein levels were decreased by 49% (p = 0.009) and total SorL1 protein levels were decreased by 29% (p = 0.003) in the brains of female Sorcs1 hypomorphic mice. From these data, we propose that dysfunction of SorCS1 may contribute to both the APP/Aß disturbance underlying AD and the insulin/glucose disturbance underlying DM.


Subject(s)
Alzheimer Disease/metabolism , Amyloid beta-Peptides/metabolism , Diabetes Mellitus, Type 2/metabolism , Membrane Transport Proteins/physiology , Receptors, Cell Surface/physiology , Receptors, LDL/physiology , Alzheimer Disease/genetics , Alzheimer Disease/physiopathology , Amyloid beta-Protein Precursor/metabolism , Animals , Cell Line , Diabetes Mellitus, Type 2/genetics , Diabetes Mellitus, Type 2/physiopathology , Disease Models, Animal , Female , Genetic Predisposition to Disease , Humans , Macromolecular Substances/metabolism , Male , Membrane Transport Proteins/deficiency , Membrane Transport Proteins/genetics , Mice , Mice, Knockout , Mice, Transgenic , Receptors, Cell Surface/genetics , Receptors, LDL/deficiency , Receptors, LDL/genetics , Vesicular Transport Proteins/deficiency , Vesicular Transport Proteins/genetics
SELECTION OF CITATIONS
SEARCH DETAIL